A federal judge has refused to dismiss putative class actions alleging that L’Oreal made outlandish claims about its anti-wrinkle products, such as that they “boost the activity of genes” and “stimulate cell regeneration.”

U.S. District Judge William Martini let stand 24 of the 26 counts in a dozen cases centralized in New Jersey, In Re L’Oreal Wrinkle Cream Marketing and Sales Practices Litigation, finding the plaintiffs sufficiently alleged fraud and other wrongs.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]